Telerehabilitation in Patients With Elevated Pulmonary Artery Pressure
The Effectiveness of Telerehabilitation in Patients With Elevated Pulmonary Artery Pressure
1 other identifier
interventional
12
1 country
1
Brief Summary
The goal of this clinical trial is to learn if synchronous telerehabilitation is effective in patients with elevated pulmonary artery pressure identified by echocardiography (systolic pulmonary artery pressure ≥50 mmHg). It will also evaluate the effects of telerehabilitation on exercise capacity, dyspnea, fatigue, functional status, and quality of life. The main questions it aims to answer are: Does synchronous telerehabilitation improve exercise and functional capacity in these patients? Does synchronous telerehabilitation improve dyspnea, fatigue, psychological status, and quality of life? Researchers will compare synchronous telerehabilitation with breathing and posture exercises to see if telerehabilitation provides greater clinical and functional benefit. Participants will: Be randomly assigned to one of 2 groups Follow an 8-week program, 3 times per week, for 30 minutes per session Perform aerobic, endurance, and strengthening exercises by synchronous telerehabilitation, or breathing and posture exercises in the control group Complete assessments before and after treatment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 10, 2026
CompletedFirst Posted
Study publicly available on registry
April 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
April 29, 2026
April 1, 2026
2 months
April 10, 2026
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Exercise Capacity
Change in 6-minute walk distance assessed by the 6-minute walk test to evaluate functional capacity.
Baseline and at 8 weeks
Dyspnea severity measured by the Modified Borg Dyspnea Scale
Change in dyspnea severity assessed using the Modified Borg Dyspnea Scale. The Modified Borg Dyspnea Scale is a subjective rating scale used to assess the severity of dyspnea at rest and/or during activity. Scores range from 0 to 10, with higher scores indicating greater dyspnea severity and a worse outcome.
Baseline and at 8 weeks
Secondary Outcomes (6)
Fatigue severity measured by the Fatigue Severity Scale
Baseline and at 8 weeks
Physical activity level
Baseline and at 8 weeks
Anxiety and depression measured by the Hospital Anxiety and Depression Scale
Baseline and at 8 weeks
Pulmonary function parameters
Baseline and at 8 weeks
Quality of life measured by the Short Form-36 (SF-36)
Baseline and at 8 weeks
- +1 more secondary outcomes
Study Arms (2)
Synchronous Telerehabilitation Group
EXPERIMENTALParticipants with elevated pulmonary artery pressure identified by echocardiography (systolic pulmonary artery pressure ≥50 mmHg) who meet the study eligibility criteria will receive an 8-week synchronous telerehabilitation program. The program will be delivered 3 days per week, 30 minutes per session, under real-time physiotherapist supervision. The intervention will include aerobic, endurance, and strengthening exercises. Exercise intensity and progression will be individualized according to clinical status, baseline adaptation, and cardiopulmonary exercise test findings. Hemodynamic parameters, oxygen saturation, dyspnea, and fatigue will be monitored during sessions.
Control Group
ACTIVE COMPARATORParticipants with elevated pulmonary artery pressure identified by echocardiography (systolic pulmonary artery pressure ≥50 mmHg) who meet the study eligibility criteria will perform breathing and posture exercises for 8 weeks. Participants in this group will continue routine care and receive weekly motivational follow-up by a physiotherapist. At the end of the study period, participants in the control group may be offered the exercise program if they wish to continue.
Interventions
A control intervention consisting of breathing exercises, positions to relieve breathing discomfort, breathing control techniques, energy conservation strategies, and posture exercises, performed for 8 weeks, together with routine care and weekly motivational follow-up.
A supervised synchronous telerehabilitation program delivered via videoconferencing, including aerobic, endurance, and strengthening exercises for 8 weeks, 3 times per week, 30 minutes per session. The program will be individualized based on participant tolerance and clinical findings, with monitoring of symptoms and physiologic responses during exercise.
Eligibility Criteria
You may qualify if:
- Adults aged 18 to 65 years
- Elevated pulmonary artery pressure identified by echocardiography, defined as systolic pulmonary artery pressure (sPAP) of 50 mmHg or higher
- Clinically stable and receiving medical treatment under cardiology follow-up World Health Organization functional class I or II
- New York Heart Association (NYHA) functional class I or II
- Living with a caregiver, family member, or another person who can provide assistance if needed
- Access to the internet and adequate visual, cognitive, and functional ability to participate in videoconference-based sessions
- Willing to participate and able to provide informed consent
You may not qualify if:
- Requirement for oxygen therapy
- Musculoskeletal problems limiting participation in exercise
- Ongoing treatment for psychiatric or psychological disorders
- Cognitive impairment based on Mini-Mental State Examination findings
- Severe chronic obstructive pulmonary disease (COPD)
- Other significant cardiac disease that may interfere with participation or assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Marmara Universitylead
- Tokat Gaziosmanpasa Universitycollaborator
Study Sites (1)
Tokat Gaziosmanpaşa University
Tokat Province, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Aysel Yıldız Özer, PhD
Marmara University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 10, 2026
First Posted
April 17, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
April 29, 2026
Record last verified: 2026-04